Real-time enrollment status for this advanced metastatic castration-resistant prostate cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:15 PM UTC
| NCT Number | NCT06217822 |
| Recruiting Status | Recruiting |
| Condition | Advanced Metastatic Castration-resistant Prostate Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 198 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Bayer |
| Last Updated on CT.gov | July 7, 2026 (6 days ago) |
As of July 13, 2026: Clinical trial NCT06217822 is currently recruiting participants. This clinical trial study for advanced metastatic castration-resistant prostate cancer is actively seeking new participants at 4 locations across the United States. The study is sponsored by Bayer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06217822 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06217822 was last updated 6 days ago (July 7, 2026). HelloStudys verifies this status automatically.